dacarbazine and Anemia

dacarbazine has been researched along with Anemia in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.67)18.7374
1990's0 (0.00)18.2507
2000's7 (46.67)29.6817
2010's7 (46.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbaro, B; Barone, C; Basso, M; Calegari, MA; Camarda, F; Cassano, A; Cenci, T; de Pascalis, I; Gori, S; Inno, A; Larocca, LM; Martini, M; Monterisi, S; Orlandi, A; Santini, D; Tonini, G1
Amatu, A; Belotti, A; Bencardino, K; Cassingena, A; Chirico, G; Esposito, A; Esteller, M; Moutinho, C; Nichelatti, M; Rusconi, F; Sartore-Bianchi, A; Siena, S1
Ansell, SM; Connors, JM; Fanale, M; Huebner, D; Hunder, NN; O'Meara, MM; Park, SI; Younes, A1
Claringbold, PG; Kesavan, M; Turner, JH1
Abdi, E; Beith, J; Corrie, PG; Kefford, RF; Kotasek, D; Margison, GP; Middleton, MR; Mortimer, P; Palmer, C; Ranson, M; Thomas, NP; Watson, AJ1
Abutarif, MA; Cantillon, M; Cutler, D; Diez, BD; Kantesaria, B; Ottaviano, FH; Pallotta, MG; Schwarz, M; Statkevich, P; Xuan, F; Zhu, Y1
Bauer, K; Brillant, C; Engert, A; Herbst, C; Kluge, S; Monsef, I; Skoetz, N1
Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT1
Ahmed, T; Lerner, R; Liu, D; Nelson, J; Seiter, K; Siddiqui, AD1
Aravantinos, G; Bafaloukos, D; Bamias, A; Carina, M; Christodoulou, C; Klouvas, G; Linardou, H; Skarlos, D1
Bertorelle, R; Biscuola, M; Blatt, V; Brandes, AA; Cavallo, G; Crinò, L; Ermani, M; Franceschi, E; Gioia, V; Tosoni, A1
Gerber, DE; Grossman, SA; Kleinberg, L; Parisi, MA; Zeltzman, M1
Angelucci, E; Baldini, L; Federico, M; Gavarotti, P; Gobbi, P; Iannitto, E; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Orsucci, L; Pavone, V; Ricardi, U; Ucci, G1
Lefebvre, PJ; Luyckx, AS1
Ascierto, PA; Cellerino, R; Comella, G; Comella, P; Daponte, A; DeLena, M; Gravina, A; Marini, G; Melucci, MT; Palmieri, G1

Reviews

1 review(s) available for dacarbazine and Anemia

ArticleYear
[The glucagonomas (author's transl)].
    Diabete & metabolisme, 1981, Volume: 7, Issue:4

    Topics: Adenoma, Islet Cell; Adult; Aged; Amino Acids; Anemia; Arginine; Body Weight; Cholesterol; Dacarbazine; Diabetes Mellitus; Diagnosis, Differential; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hypoproteinemia; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Somatostatin; Streptozocin; Thrombophlebitis; Zinc

1981

Trials

12 trial(s) available for dacarbazine and Anemia

ArticleYear
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation.
    British journal of cancer, 2017, May-09, Volume: 116, Issue:10

    Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; GTP Phosphohydrolases; Humans; Membrane Proteins; Middle Aged; Mutation; Nausea; Neoplasm Metastasis; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Retreatment; Survival Rate; Temozolomide; Thrombocytopenia; Treatment Outcome; Tumor Suppressor Proteins; Vomiting

2017
Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Apr-15, Volume: 19, Issue:8

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Constipation; CpG Islands; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nausea; Prognosis; Promoter Regions, Genetic; Treatment Outcome; Tumor Suppressor Proteins

2013
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.
    The Lancet. Oncology, 2013, Volume: 14, Issue:13

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Immunoconjugates; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Treatment Outcome; Vinblastine

2013
Hematological toxicity of combined 177Lu-octreotate radiopeptide chemotherapy of gastroenteropancreatic neuroendocrine tumors in long-term follow-up.
    Neuroendocrinology, 2014, Volume: 99, Issue:2

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Blood Platelets; Capecitabine; Dacarbazine; Deoxycytidine; Digestive System Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Hematologic Diseases; Humans; Incidence; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Neutrophils; Octreotide; Pancreatic Neoplasms; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Stomach Neoplasms; Temozolomide; Thrombocytopenia; Treatment Outcome

2014
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.
    British journal of cancer, 2009, Apr-21, Volume: 100, Issue:8

    Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Child; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Patient Selection; Purines; Skin Neoplasms; Temozolomide; Thrombocytopenia

2009
Evaluation of the exposure equivalence of oral versus intravenous temozolomide.
    Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:4

    Topics: Administration, Oral; Adult; Anemia; Antineoplastic Agents, Alkylating; Area Under Curve; Central Nervous System Neoplasms; Constipation; Cross-Over Studies; Dacarbazine; Drug Administration Schedule; Female; Headache; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Temozolomide; Therapeutic Equivalency; Time Factors; Vomiting

2010
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:3

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2012
Evaluation of temozolomide in patients with myelodysplastic syndrome.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:6

    Topics: Aged; Anemia; Antineoplastic Agents, Alkylating; Cardiomyopathies; Dacarbazine; Drug Evaluation; Female; Fever; Humans; Male; Maximum Tolerated Dose; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Temozolomide; Treatment Failure

2004
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
    Journal of neuro-oncology, 2005, Volume: 71, Issue:1

    Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Dacarbazine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Stomach Neoplasms; Temozolomide; Treatment Outcome

2005
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).
    British journal of cancer, 2006, Nov-06, Volume: 95, Issue:9

    Topics: Adult; Aged; Anemia; Antineoplastic Agents, Alkylating; Brain Neoplasms; Constipation; Dacarbazine; Disease Progression; DNA Methylation; Drug Administration Schedule; Female; Glioblastoma; Humans; Lymphopenia; Male; Middle Aged; Neoplasm Recurrence, Local; O(6)-Methylguanine-DNA Methyltransferase; Survival Analysis; Temozolomide; Treatment Outcome

2006
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Heart Diseases; Hodgkin Disease; Humans; Infections; Italy; Leukopenia; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vinblastine

2008
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Cancer, 2000, Dec-15, Volume: 89, Issue:12

    Topics: Adult; Aged; Anemia; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; CD146 Antigen; Cisplatin; Dacarbazine; Female; Fever; Follow-Up Studies; Humans; Interferon-alpha; Male; MART-1 Antigen; Melanoma; Melanoma-Specific Antigens; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Nausea; Neoplasm Proteins; Neural Cell Adhesion Molecules; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting

2000

Other Studies

2 other study(ies) available for dacarbazine and Anemia

ArticleYear
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
    Journal of the National Cancer Institute, 2010, Jun-16, Volume: 102, Issue:12

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Bleomycin; Chlorambucil; Controlled Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Exercise; Hematinics; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multicenter Studies as Topic; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Quality of Life; Randomized Controlled Trials as Topic; Vinblastine; Vincristine

2010
The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas.
    Neuro-oncology, 2007, Volume: 9, Issue:1

    Topics: Adult; Aged; Anemia; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Glioma; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Temozolomide; Thrombocytopenia; Treatment Outcome

2007